1-(3-bromobenzyl)-3-(3-(4-chlorophenyl)-1,2,4-oxadiazol-5-yl)-7-methyl-1,8-naphthyridin-4(1H)-one structure
|
Common Name | 1-(3-bromobenzyl)-3-(3-(4-chlorophenyl)-1,2,4-oxadiazol-5-yl)-7-methyl-1,8-naphthyridin-4(1H)-one | ||
|---|---|---|---|---|
| CAS Number | 1032001-40-3 | Molecular Weight | 507.8 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C24H16BrClN4O2 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
| Name | 1-(3-bromobenzyl)-3-(3-(4-chlorophenyl)-1,2,4-oxadiazol-5-yl)-7-methyl-1,8-naphthyridin-4(1H)-one |
|---|
| Molecular Formula | C24H16BrClN4O2 |
|---|---|
| Molecular Weight | 507.8 |
| InChIKey | VMCMFIYTLRKQKJ-UHFFFAOYSA-N |
| SMILES | Cc1ccc2c(=O)c(-c3nc(-c4ccc(Cl)cc4)no3)cn(Cc3cccc(Br)c3)c2n1 |
|
Name: Primary screen in NF54 nanoGlo assay, in single point, at 2uM, 72h
Source: ChEMBL
Target: Plasmodium falciparum
External Id: CHEMBL4888485
|
|
Name: High-throughput screen for inhibitors of the GIV GBA-motif interaction with Galpha-i ...
Source: ICCB-Longwood/NSRB Screening Facility, Harvard Medical School
External Id: HMS1303
|